Akero Therapeutics, Inc. Operating Lease Cost
Akero Therapeutics, Inc. reported Operating Lease Cost of $81.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2025-05-12
- Akero Therapeutics, Inc. operating lease, cost for the quarter ending 2025-03-31 was $81.00K, a 0.00% change year-over-year.
- Akero Therapeutics, Inc. operating lease, cost for the quarter ending 2024-03-31 was $81.00K.
| Period end | Operating Lease, Cost 3 month |
|---|---|
| 2025-03-31 | $81.00K 10-Q · filed 2025-05-12 |
| 2024-03-31 | $81.00K 10-Q · filed 2025-05-12 |